Enochian Biosciences

+$0.15 (+2.08%) Today
-$0.06 (-0.82%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENOB and other ETFs, options, and stocks.

About ENOB

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.

CEO
Mark Richard Dybul
Employees
10
Headquarters
Los Angeles, California
Founded
2011

ENOB Key Statistics

Market Cap
382.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
206.26K
High Today
$7.60
Low Today
$7.17
Open Price
$7.26
Volume
203.13K
52 Week High
$12.99
52 Week Low
$2.60

ENOB Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Oct 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure